AVTX
Avalo Therapeutics, Inc.
$17.88
-0.67 (-3.61%)
At close · Jul 16
Market Cap
$939.87M
Shares
52,565,572
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-02 | JONATHAN GOLDMAN | Director | 42,833 | 2026-06-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | CHRISTOPHER SULLIVAN | Officer | 18,606 | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-06 | MITCHELL CHAN | Director | 3,167 | 2026-05-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-06 | MITTIE DOYLE | Officer | 54,508 | 2026-05-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-06 | PAUL VARKI | Officer | 92,771 | 2026-05-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-06 | CHRISTOPHER SULLIVAN | Officer | 47,000 | 2026-05-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-29 | CHRISTOPHER SULLIVAN | Officer | 16,915 | 2026-04-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-06 | MITTIE DOYLE | Officer | 65,800 | 2026-04-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-01 | CHRISTOPHER SULLIVAN | Officer | 15,959 | 2026-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-16 | MITTIE DOYLE | Officer | 29,529 | 2026-03-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–10 of 10 filings